World's Best Scientists 2026 revealed!
David Durantel

David Durantel

D-Index & Metrics

Immunology

D-Index
54
Citations
11114
World Ranking
3883
National Ranking
181

David Durantel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David Durantel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 212 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David Durantel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David Durantel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David Durantel is affiliated with Inserm in France and has focused their research primarily in the field of Medicine, contributing to 121 publications. Their work spans several subfields including Epidemiology, Hepatology, Immunology, Infectious Diseases, and Molecular Biology. The main research topics covered by Durantel include Hepatitis B Virus Studies, Hepatitis C Virus Research, Liver Disease Diagnosis and Treatment, interferon and immune responses, Hepatitis Viruses Studies and Epidemiology, RNA modifications and cancer, and Viral Infections and Outbreaks Research.

Durantel has frequently published in these scientific venues:

  • Journal of Hepatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Antiviral Research
  • JHEP Reports
  • Scientific Reports

Frequent coauthors associated with Durantel's research include Julie Lucifora, Anna Salvetti, Michel Rivoire, Caroline Pons, and Maud Michelet. These collaborations highlight an active engagement in multidisciplinary groups focused on viral hepatology and immunological responses.

Among Durantel's recent publications are:

  • "COVID-19: Discovery, diagnostics and drug development" (2020) in Journal of Hepatology
  • "Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion" (2021) in eLife
  • "Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma" (2020) in Theranostics
  • "RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes" (2021) in Gut
  • "Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production" (2020) in PLoS Pathogens

The scientist's research contributions have covered viral pathogenesis, immune system interactions, and molecular mechanisms underlying hepatitis B virus replication and liver cancer development. Their work also touches on immune exhaustion and antiviral responses relevant to chronic hepatitis B infection.

Best Publications

  • Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

    Lars Petter Jordheim;David Durantel;Fabien Zoulim;Charles Dumontet

  • Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

    Julie Lucifora;Yuchen Xia;Florian Reisinger;Ke Zhang

  • Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection

    Julie Lucifora;Silke Arzberger;David Durantel;David Durantel;David Durantel;Laura Belloni;Laura Belloni

  • COVID-19: Discovery, diagnostics and drug development.

    Tarik Asselah;David Durantel;Eric Pasmant;George Lau

  • Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

    Jean-Pierre Villeneuve;David Durantel;Sandra Durantel;Christopher Westland

  • Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

    Marie-Noëlle Brunelle;Anne-Carole Jacquard;Christian Pichoud;David Durantel

  • Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

    Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau

  • New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus

    David Durantel;Fabien Zoulim

  • Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B

    Fabien Zoulim;David Durantel

  • Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

    Olivier Hantz;Olivier Hantz;Romain Parent;Romain Parent;David Durantel;David Durantel;Philippe Gripon

  • A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

    Eloi R. Verrier;Che C. Colpitts;Charlotte Bach;Laura Heydmann

  • Study of the Mechanism of Antiviral Action of Iminosugar Derivatives against Bovine Viral Diarrhea Virus

    David Durantel;Norica Branza-Nichita;Sandra Carrouée-Durantel;Terry D. Butters

  • Control of hepatitis B virus replication by innate response of HepaRG cells

    Julie Lucifora;Julie Lucifora;David Durantel;David Durantel;David Durantel;Barbara Testoni;Barbara Testoni;Olivier Hantz;Olivier Hantz

  • Early inhibition of hepatocyte innate responses by hepatitis B virus

    Souphalone Luangsay;Marion Gruffaz;Marion Gruffaz;Nathalie Isorce;Nathalie Isorce;Barbara Testoni;Barbara Testoni

  • Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.

    Marlène Dreux;Viet Loan Dao Thi;Judith Fresquet;Maryse Guérin

  • Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.

    Fanny Lebossé;Fanny Lebossé;Barbara Testoni;Barbara Testoni;Judith Fresquet;Judith Fresquet;Floriana Facchetti

  • The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies.

    Marie-Jeanne Marion;Olivier Hantz;David Durantel;David Durantel

  • Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells

    Alina Macovei;Cristina Radulescu;Catalin Lazar;Stefana Petrescu

  • Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.

    Norica Branza-Nichita;David Durantel;Sandra Carrouée-Durantel;Raymond A. Dwek

  • RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.

    Hao Zhang;Zheng Xing;Saravana Kumar Kailasam Mani;Brigitte Bancel

  • Case report Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

    Jean-Pierre Villeneuve;David Durantel;Sandra Durantel;Christopher Westland

Frequent Co-Authors

Christian Trepo
Christian Trepo Hospices Civils de Lyon
Nicole Zitzmann
Nicole Zitzmann University of Oxford
Raymond A. Dwek
Raymond A. Dwek University of Oxford
Ulrike Protzer
Ulrike Protzer Technical University of Munich
François-Loïc Cosset
François-Loïc Cosset Claude Bernard University Lyon 1
Jean Dubuisson
Jean Dubuisson Institut Pasteur
Mathias Heikenwalder
Mathias Heikenwalder German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing Immunology, branching into specialized healthcare roles is a common pathway. Many graduates explore options such as Psychiatric Mental Health Nurse Practitioner (PMHNP) programs, which are available in various formats including online. Choosing the right program can be crucial, and checking out resources that highlight the best pmhnp programs online helps ensure strong clinical placements and quality education.

Cost is another key factor. For students mindful of tuition fees, the cheapest pmhnp programs online offer valuable information to find budget-friendly yet reputable courses. This can ease the financial burden while still advancing a healthcare career related to Immunology.

Career prospects following degree completion are promising, especially in nursing roles requiring specialized certification. Understanding how much do dnp nurses make provides insight into potential earnings, which vary by state and specialization.

For those already certified as Family Nurse Practitioners, pathways exist to further specialize. For example, pursuing an fnp to acute care certification is a recognized route that expands clinical skills and job opportunities, complementing Immunology-related fields.

Best Scientists Citing David Durantel

Trending Scientists

Recently Published Articles